Formulation preference, tolerability and quality of life assessment following a switch from lopinavir/ritonavir soft gel capsule to tablet in human immunodeficiency virus-infected patients

BACKGROUND: Lopinavir/ritonavir (LPV/r) tablet compared to the soft gel capsule (SGC) formulation has no oleic acid or sorbitol, has no refrigeration or food-restriction requirements, and has less pharmacokinetic variability. We compared the tolerability, quality of life (QoL), and formulation prefe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ofotokun, Ighovwerha, Chuck, Susan K, Schmotzer, Brian, O'Neil, Kelly L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809072/
https://www.ncbi.nlm.nih.gov/pubmed/20028544
http://dx.doi.org/10.1186/1742-6405-6-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809072/
https://www.ncbi.nlm.nih.gov/pubmed/20028544
http://dx.doi.org/10.1186/1742-6405-6-29

Ejemplares similares